File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Preliminary on-treatment data from a phase 2 study evaluating VIR-2218 in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection

TitlePreliminary on-treatment data from a phase 2 study evaluating VIR-2218 in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection
Authors
Issue Date2021
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
The International Liver Congress 2021 (ILC 2021): Beating Liver Disease Together, Virtual Conference, 23-26 June 2021, In Journal of Hepatology, 2021, v. 75 n. Suppl. 2, p. S738-S739 How to Cite?
DescriptionLate breaker posters: Poster presentation: PO-824
Persistent Identifierhttp://hdl.handle.net/10722/306180
ISSN
2021 Impact Factor: 30.083
2020 SCImago Journal Rankings: 7.112

 

DC FieldValueLanguage
dc.contributor.authorYuen, RMF-
dc.contributor.authorLim, YS-
dc.contributor.authorCloutier, D-
dc.contributor.authorShen, L-
dc.contributor.authorArizpe, A-
dc.contributor.authorPang, P-
dc.contributor.authorTay, C-
dc.contributor.authorThanawala, V-
dc.contributor.authorGupta, SV-
dc.contributor.authorCathcart, A-
dc.contributor.authorGane, E-
dc.date.accessioned2021-10-20T10:19:56Z-
dc.date.available2021-10-20T10:19:56Z-
dc.date.issued2021-
dc.identifier.citationThe International Liver Congress 2021 (ILC 2021): Beating Liver Disease Together, Virtual Conference, 23-26 June 2021, In Journal of Hepatology, 2021, v. 75 n. Suppl. 2, p. S738-S739-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/306180-
dc.descriptionLate breaker posters: Poster presentation: PO-824-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.relation.ispartofThe International Liver Congress 2021 (ILC 2021)-
dc.titlePreliminary on-treatment data from a phase 2 study evaluating VIR-2218 in combination with pegylated interferon alfa-2a in participants with chronic hepatitis B infection-
dc.typeConference_Paper-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.authorityYuen, RMF=rp00479-
dc.description.natureabstract-
dc.identifier.hkuros326610-
dc.identifier.volume75-
dc.identifier.issueSuppl. 2-
dc.identifier.spageS738-
dc.identifier.epageS739-
dc.publisher.placeNetherlands-
dc.identifier.partofdoi10.1016/S0168-8278(21)01843-2-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats